Faculty Opinions recommendation of Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548131.793003144 ◽

2012 ◽

Author(s):

Ian Beales

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial ◽

First Line Therapy ◽

Line Therapy ◽

Biomarker Evaluation

Download Full-text

Faculty Opinions recommendation of Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717548131.793152982 ◽

2012 ◽

Author(s):

Mitesh Borad

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial ◽

First Line Therapy ◽

Line Therapy ◽

Biomarker Evaluation

Download Full-text

A Randomized, Controlled Phase III Trial of Docetaxel, Cisplatin and Fluorouracil (DCF) versus Cisplatin Plus Fluorouracil (CF) as First-Line Therapy in Chinese advanced Gastric Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33266-x ◽

2012 ◽

Vol 23 ◽

pp. ix231

Author(s):

L. Shen ◽

R. Xu ◽

J. Wang ◽

Y. Bai ◽

T. Liu ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial ◽

Randomized Controlled ◽

First Line Therapy ◽

Line Therapy

Download Full-text

3501 ORAL Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC): a randomised phase III trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71004-2 ◽

2007 ◽

Vol 5 (4) ◽

pp. 259 ◽

Cited By ~ 6

Author(s):

Y. Kang ◽

W. Kang ◽

D. Shin ◽

J. Chen ◽

J. Xiong ◽

...

Keyword(s):

Gastric Cancer ◽

Continuous Infusion ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Phase Iii Trial ◽

Oral Capecitabine ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Annals of Oncology ◽

10.1093/annonc/mdn717 ◽

2009 ◽

Vol 20 (4) ◽

pp. 666-673 ◽

Cited By ~ 477

Author(s):

Y.-K. Kang ◽

W.-K. Kang ◽

D.-B. Shin ◽

J. Chen ◽

J. Xiong ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Noninferiority Trial

Download Full-text

6509 5-FU/l-LV (RPMI) versus S-1 as first-line therapy in patients with advanced gastric cancer: a randomized phase III non-inferiority trial. (ISO-5FU10 Study Group trial)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71231-5 ◽

2009 ◽

Vol 7 (2) ◽

pp. 364 ◽

Cited By ~ 15

Author(s):

A. Sawaki ◽

K. Yamaguchi ◽

Y. Nabeya ◽

Y. Sakai ◽

H. Osanai ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

Study Group ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Group Trial

Download Full-text

Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation

European Journal of Cancer ◽

10.1016/j.ejca.2016.09.024 ◽

2017 ◽

Vol 70 ◽

pp. 146-155 ◽

Cited By ~ 60

Author(s):

David Miles ◽

David Cameron ◽

Igor Bondarenko ◽

Lyudmila Manzyuk ◽

Juan Carlos Alcedo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

First Line ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

First Line Therapy ◽

Line Therapy ◽

Biomarker Evaluation

Download Full-text

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Yearbook of Oncology ◽

10.1016/j.yonc.2012.05.013 ◽

2012 ◽

Vol 2012 ◽

pp. 138-139 ◽

Cited By ~ 1

Author(s):

E.G. Chiorean

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

First Line Therapy ◽

Line Therapy ◽

Phase Iii Study

Download Full-text

Non Inferiority Analysis of Multicenter Phase III Comparing Cisplatin/S-1 (CS) with Cisplatin/5-Fu (CF) as First-Line Therapy in Patients with advanced Gastric Cancer (FLAGS): Methodology and Results

Annals of Oncology ◽

10.1016/s0923-7534(20)33261-0 ◽

2012 ◽

Vol 23 ◽

pp. ix224-ix225 ◽

Cited By ~ 1

Author(s):

J.A. Ajani ◽

W. Rodriguez Pantigoso ◽

G. Bodoky ◽

V. Moiseyenko ◽

M. Lichinitser ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Line Therapy

Download Full-text

gastrointestinal tumours, non-colorectal Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy: Phase III GOLD study

Annals of Oncology ◽

10.1093/annonc/mdw435.16 ◽

2016 ◽

Vol 27 ◽

pp. vi562 ◽

Cited By ~ 6

Author(s):

Y.-J. Bang ◽

N. Boku ◽

K. Chin ◽

K.-W. Lee ◽

S.H. Park ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Gastrointestinal Tumours

Download Full-text

A phase III study to compare the efficacy and safety of paclitaxel versus irinotecan in patients with metastatic or recurrent gastric cancer who failed in first-line therapy (KCSG ST10-01)

Annals of Oncology ◽

10.1093/annonc/mdy282.064 ◽

2018 ◽

Vol 29 ◽

pp. viii228-viii229

Author(s):

K.-W. Lee ◽

C.H. Maeng ◽

T.-Y. Kim ◽

D.Y. Zang ◽

Y.H. Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

Phase Iii Study

Download Full-text